je.st
news
Tag: portfolio
Why Pepsi, Time Warner Should Be in Your Portfolio
2015-07-30 19:12:25| Paper - Topix.net
"We think they are very much focused on cutting costs and that's part of what is generating growth," said Warne. "We think that is really good news for investors because it's a diversified portfolio of snacks and drinks and that should give it the growth over time to support not only the current 3% yield but dividend growth and that's really attractive for investors right now."
Tags: your
time
portfolio
warner
Rohde & Schwarz And Its 4K Product Portfolio At IBC 2015: More Than Just Resolution
2015-07-30 18:41:16| rfglobalnet News Articles
Rohde & Schwarz will present its new products at IBC 2015 in Amsterdam from September 11 to 15. The next generation of the R&S CLIPSTER mastering station will make its debut at IBC. The R&S CLIPSTER will bring I/O, image processing and codec acceleration to a new level, and is perfect for high-end post production workflows, e.g. in 4K UHD, with high frame rates, or using Rec. 2020.
Rohde & Schwarz to Showcase Its Comprehensive Portfolio of EMC Test Solutions at EMC 2015 in Dresden
2015-07-30 12:31:09| Industrial Newsroom - All News for Today
At EMC 2015 in Dresden, Rohde Schwarz will demonstrate its expertise in electromagnetic compatibility measurements. The companys portfolio includes EMI test receivers and precompliance test receivers, highly sophisticated, harmonized system solutions, as well as the appropriate test and analysis software and...
Tags: in
test
solutions
comprehensive
Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics
2015-07-28 12:45:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. & MISGAV, Israel KENILWORTH, N.J. & MISGAV, Israel--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and cCAM Biotherapeutics announced today that the companies have signed a definitive agreement under which Merck will acquire cCAM Biotherapeutics, a privately held biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies. Language: English Contact: Merck Media Relations:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orMerck Investor Relations:Justin Holko, 908-740-1879orcCAM Investor/Media Relations:Tsipi Haitovsky, +972-525-989892 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: portfolio
acquisition
enhances
merck
SunPower acquires US solar project portfolio from Infigen Energy
2015-07-28 01:00:00| Power Technology
American solar manufacturer SunPower has acquired a portfolio of 1.5GW of solar power plant assets under development in the US states, from Australia-based Infigen Energy.
Tags: project
energy
portfolio
solar
Sites : [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] next »